AlexeyAleshinMD

PubMed

• 72 citations
  Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.
  Bernadett Szabados, Mark Kockx, Zoe June Assaf, Pieter-Jan van Dam, Alejo Rodriguez-Vida
  European Urology. 2022-08-01
• 40 citations
  Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.
  Mark Jesus M Magbanua, Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W Sayaman, Derrick Renner
  Cancer Cell. 2023-06-12
• 43 citations
  Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitro
  Richard S. Finn, Alexey Aleshin, Judy Dering, Peter C. Yang, Charles Ginther
  Hepatology. 2013-05-01

Abstracts/Posters

• A Feasibility Study of Biologically Focused Therapy for Myelodysplastic Syndrome Patients Refractory to Hypomethylating Agents
  Alexey Aleshin, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

• Single-Cell Mutational Profiling of Clonal Evolution in De Novo AML during Therapy and Relapse 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018